YLYan-Li Liu

Yan-Li Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yan-Li Liu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Cheng Wang

    Department of Pharmacy, Suzhou Science and Technology Town Hospital, Suzhou, China

    1 shared publication
  • Ke-Ke Cao

    Department of Quality management, Shenzhen Yuanxing gene-tech Co. Ltd , Shenzhen , China

    1 shared publication
  • Nai-Xin Kang

    College of Pharmaceutical Science, Soochow University , Suzhou , China

    1 shared publication
  • Qiong-Ming Xu

    College of Pharmaceutical Science, Soochow University , Suzhou , China

    1 shared publication
  • Shi-Liang Ji

    Department of pharmacy, The Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University , Suzhou , China

    1 shared publication
  • Shi-Lin Yang

    College of Pharmaceutical Science, Soochow University , Suzhou , China

    1 shared publication

Latest Publications

  • Antioxidant activity of phenylethanoid glycosides on glutamate-induced neurotoxicity

    by Shi-Liang Ji, Ke-Ke Cao, Xing-Xing Zhao, Nai-Xin Kang, Ying Zhang, Qiong-Ming Xu, Shi-Lin Yang, Yan-Li Liu, Cheng Wang

    Exposure of PC12 cells to 10 mM glutamate caused significant viability loss, cell apoptosis, decreased activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) as well as increased levels of malondialdehyde (MDA). In parallel, glutamate significantly increased the intracellular levels of ROS and intracellular calcium. However, pretreatment of the cells with acteoside and isoacteoside significantly suppressed glutamate-induced cellular events. Moreover, acteoside and isoacteoside reduced the glutamate-induced increase of caspase-3 activity and also ameliorated the glutamate-induced Bcl-2/Bax ratio reduction in PC12 cells. Furthermore, acteoside and isoacteoside significantly inhibited glutamate-induced DNA damage. In the mouse model, acteoside significantly attenuated cognitive deficits in the Y maze test and attenuated neuronal damage of the hippocampal CA1 regions induced by glutamate. These data indicated that acteoside and isoacteoside play neuroprotective effects through anti-oxidative stress, anti-apoptosis, and maintenance of steady intracellular calcium.